AOD-9604

What is AOD-9604?

AOD-9604 is a short peptide fragment derived from the tail end of human growth hormone, specifically a 16-amino-acid piece once nicknamed the “fat-burning fragment.” The theory was that this fragment could trigger fat breakdown like growth hormone does, without growth hormone’s effects on blood sugar or tissue growth. It is not an approved drug. It is sold and labeled as research-use-only, and it is not authorized as a treatment for fat loss or anything else.

What does AOD-9604 claim to do?

The central claim is targeted fat loss. That AOD-9604 ramps up the breakdown of stored fat and discourages new fat formation, supposedly without affecting blood sugar. Some marketers stretch further into claims about joint and cartilage repair.

Why do people use AOD-9604?

The pitch is seductive: the “fat-burning part” of growth hormone with none of the downsides. It is popular in some peptide and bodybuilding circles and at certain wellness clinics, marketed as a leaner, “cleaner” alternative to growth hormone. The appeal is essentially the dream of fat loss without lifestyle change.

What does the science actually say about AOD-9604?

Here the gap between marketing and evidence is wide. AOD-9604 showed promising fat-loss effects in animal studies, which is what generated the early excitement. But when it was tested in humans as a weight-loss candidate, the results were disappointing: in clinical testing it did not produce meaningful weight loss beyond placebo, and its development as an obesity drug was essentially abandoned. That is a crucial fact the marketing tends to omit.

It has been evaluated for other uses, including osteoarthritis, but it has not earned approval as a medicine for any of these indications. The “obtained GRAS-like” or food-supplement framing some sellers use does not equal proven clinical benefit, and it does not make it an approved treatment.

For longevity specifically, there is essentially no human evidence that AOD-9604 slows aging, improves healthspan, or does anything beyond what the failed weight-loss trials showed. The compelling story rests largely on animal data and testimonials.

How do people use AOD-9604?

In peptide and clinic settings it is typically reported as a daily subcutaneous injection of a small dose, sometimes timed before fasted exercise, described here only as what is reported, not as instructions. Because the product is research-grade and unregulated, purity and actual content vary widely. This book does not provide sourcing or self-administration guidance, and anyone exploring it should do so only under a knowledgeable physician’s supervision.

Is AOD-9604 safe? Risks and who should skip it

AOD-9604 has generally been reported as well-tolerated in trials, but “well-tolerated in a failed trial” is not the same as “safe to inject from an unregulated vial.” The real risks are unknown long-term effects and, more immediately, contamination, mislabeling, and incorrect dosing in gray-market product. It should be skipped by anyone who is pregnant, has a history of cancer or growth disorders, or is unwilling to involve a doctor.

The bottom line on AOD-9604

AOD-9604 is a great example of a peptide whose marketing outran its evidence: it failed as a weight-loss drug in humans and has no longevity data behind it. Interesting in theory, unproven in practice, and not an approved treatment.